Tice BCG 50 MG Powder for Intravesical Suspension
- RxCUI
- 213744
- RxNorm name
- Tice BCG 50 MG Powder for Intravesical Suspension
- Display name
- Tice BCG 50 MG Powder for Intravesical Suspension
- Full name
- Tice BCG 50 MG Powder for Intravesical Suspension
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:21
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 102821 | Tice Bcg | BCG Live | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TICE BCG | BACILLUS CALMETTE-GUERIN | Merck Sharp & Dohme LLC | c9b74876-e665-442b-87ad-b7333bc9a67a | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | 213744 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c9b74876-e665-442b-87ad-b7333bc9a67a | Tice BCG 50 MG Powder for Intravesical Suspension | PSN | 22 | TICE ® BCG BCG Live For Intravesical Use | 20260220 |
| c9b74876-e665-442b-87ad-b7333bc9a67a | Tice BCG 50 MG Powder for Intravesical Suspension | SY | 22 | TICE ® BCG BCG Live For Intravesical Use | 20260220 |
| c9b74876-e665-442b-87ad-b7333bc9a67a | BCG, live, Tice strain 50 MG Powder for Intravesical Suspension [Tice BCG] | SBD | 22 | TICE ® BCG BCG Live For Intravesical Use | 20260220 |